Skip to main content
Clinical Trials/NCT07343011
NCT07343011RecruitingNot Applicable

Conjunctival Transpositional Pterygium Surgery: A Prospective Single-Arm Interventional Study

Zahedan University of Medical Sciences1 site in 1 country70 target enrollmentStarted: May 21, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
Pterygium Recurrence

Study Overview

Brief Summary

This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 years or older
  • Primary pterygium involving the cornea
  • Ability to provide informed consent

Exclusion Criteria

  • Recurrent pterygium
  • Previous ocular surface surgery
  • Active ocular infection or inflammation
  • Severe ocular surface disease

Outcomes

Primary Outcomes

Pterygium Recurrence

Time Frame: 12 months

Recurrence is defined as fibrovascular regrowth toward the cornea or surgical failure.

Secondary Outcomes

  • Visual Acuity(12 months)
  • Refractive Astigmatism(12 months)

Investigators

Sponsor
Zahedan University of Medical Sciences
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohammed Arish

Associate professor of ophthalmology

Zahedan University of Medical Sciences

Study Sites (1)

Loading locations...

Similar Trials

Conjunctival Transpositional Surgery for... | Clinical Trial